Recent studies suggest the shingles vaccine, specifically Shingrix, may offer benefits beyond preventing painful outbreaks. Data indicates the vaccine is associated with slower biological aging, reduced inflammation, and even protection against cardiac events and cognitive decline.
Inflammation, Aging, and the Shingles Vaccine
Chronic, low-grade inflammation—often called “inflammaging”—is a key driver of age-related diseases like heart disease and dementia. The shingles vaccine appears to counteract this process. A study analyzing data from over 18,700 U.S. adults aged 50+ found that vaccinated individuals had 17% lower levels of C-reactive protein (CRP), a key inflammatory marker, compared to unvaccinated participants.
Researchers also measured epigenetic aging using DunedinPACE, a tool that assesses the rate of biological aging at the cellular level. The results showed that those vaccinated against shingles exhibited signs of slower aging compared to their unvaccinated counterparts. This suggests the vaccine isn’t just preventing a disease; it may be slowing down the body’s overall decline.
Broader Health Benefits
The vaccine’s effects extend beyond inflammation. Additional research has linked it to:
- Reduced risk of cardiac events: Studies indicate the vaccine can cut the rate of serious heart problems in half for those with pre-existing heart disease.
- Cognitive protection: The vaccine may prevent or delay dementia and mild cognitive impairment.
- Lower mortality risk: Vaccinated individuals with dementia had a reduced risk of death.
How It Works: Viral Control and Immune Modulation
The shingles vaccine appears to work through multiple mechanisms. First, it prevents the reactivation of the varicella-zoster virus (the virus responsible for both chickenpox and shingles), reducing the inflammatory burden on the body. Second, the adjuvant in Shingrix (AS01B) boosts the immune response and may have broader immune-modulating effects that benefit overall health.
Biological vs. Chronological Age
It’s important to distinguish between chronological age (years lived) and biological age (how your cells and tissues function). Two 55-year-olds can have vastly different biological ages depending on genetics, lifestyle, and now, potentially, vaccination status.
Who Should Get Vaccinated?
The CDC recommends the shingles vaccine for:
- Adults 50 and older
- Adults 19 and older with weakened immune systems
The vaccine is administered in a two-dose series, with the second shot given 2 to 6 months after the first. It can also prevent future shingles episodes for those who have already had the virus.
In conclusion, emerging research suggests the shingles vaccine may slow down biological aging, reduce inflammation, and provide broader health benefits beyond simply preventing the disease. While observational studies cannot prove causation, the biological plausibility and growing evidence make this a compelling argument for considering vaccination.
